COVID-19 and HIV/AIDS in a cohort study in Sao Paulo, Brazil: outcomes and disparities by race and schooling
Carregando...
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
Autores
ROCHA, S. Q.
TANCREDI, M. V.
JAMAL, L. F.
FERREIRA, P. R. A.
TAYRA, A.
FERREIRA, P. M.
CARVALHANAS, T.
DOMINGUES, C. S. B.
SOUZA, R. A.
Citação
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, v.34, n.7, p.832-838, 2022
Resumo
Studies describing characteristics and outcomes of COVID-19 among people living with HIV are currently limited, lacking detailed evaluation of the interplay among demographics, HIV-related variables, and comorbidities on COVID-19 outcomes. This retrospective cohort study describes mortality rates overall and according to demographic characteristics and explores predictors of admission to intensive care unit and death among 255 persons living with HIV with severe acute respiratory syndrome and confirmed SARS-CoV-2 infection in the State of Sao Paulo, Brazil. We found that the overall mortality rate was 4.1/1,000 person-days, with a case-fatality of 34%. Higher rates occurred among older adults, Black/Mixed skin color/race patients, and those with lower schooling. In a multivariable analysis adjusted for age, sex, CD4 count, viral load and number of comorbidities, skin color/race, and schooling remained significantly associated with higher mortality. Although tenofovir use was more frequent among survivors in the univariable analysis, we failed to find a statistically significant association between tenofovir use and survival in the multivariable analysis. Our findings suggest that social vulnerabilities related to both HIV and COVID-19 significantly impact the risk of death, overtaking traditional risk factors such as age, sex, CD4 count, and comorbidities.
Palavras-chave
HIV, SARS-CoV-2, COVID-19, mortality, race, schooling
Referências
- [Anonymous], 2020, NOVO CORONAVIRUS COV
- [Anonymous], IND DAD BAS MON CLIN
- [Anonymous], 2019, DESIGUALDADES SOCIAI
- Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
- Bozza, 2020, ANAL SOCIOECONOMICA
- Chan K. S., 2003, Hong Kong Medical Journal, V9, P399
- Chen XP, 2003, JAIDS-J ACQ IMM DEF, V34, P242, DOI 10.1097/00126334-200310010-00016
- Dandachi D, 2021, CLIN INFECT DIS, V73, pE1964, DOI 10.1093/cid/ciaa1339
- Dayer MR, 2017, ARCH CLIN INFECT DIS, V12, DOI 10.5812/archcid.13823
- del Amo J, 2020, ANN INTERN MED, V173, P536, DOI 10.7326/M20-3689
- Elfiky AA, 2020, LIFE SCI, V253, DOI 10.1016/j.lfs.2020.117592
- de Souza CDF, 2020, J BRAS PNEUMOL, V46, DOI 10.36416/1806-3756/e20200208
- Gervasoni C, 2020, CLIN INFECT DIS, V71, P2276, DOI 10.1093/cid/ciaa579
- Goes Emanuelle Freitas, 2020, Trab. educ. saúde, V18, pe00278110, DOI 10.1590/1981-7746-sol00278
- Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020
- Guo W., 2020, SURVEY COVID 19 HIV, DOI 10.2139/ssrn.3550029
- Harter G, 2020, INFECTION, V48, P681, DOI 10.1007/s15010-020-01438-z
- Jockusch S, 2020, ANTIVIR RES, V180, DOI 10.1016/j.antiviral.2020.104857
- Melchjorsen J, 2011, JAIDS-J ACQ IMM DEF, V57, P265, DOI 10.1097/QAI.0b013e3182185276
- Meyer B, 2015, CRIT CARE MED, V43
- Ministry of Health and Social Services, 2010, NAT HLTH POL FRAM 20
- Parohan M, 2020, AGING MALE, V23, P1416, DOI 10.1080/13685538.2020.1774748
- Ryan C, 2021, AM J EMERG MED, V45, P378, DOI 10.1016/j.ajem.2020.09.017
- Sachdev D, 2021, JAIDS-J ACQ IMM DEF, V86, P19, DOI 10.1097/QAI.0000000000002531
- Sigel K, 2020, CLIN INFECT DIS, V71, P2933, DOI 10.1093/cid/ciaa880
- Ssentongo P, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85359-3
- Szklo M, 2004, EPIDEMIOLOGY BASICS
- Tancredi MV, 2014, T ROY SOC TROP MED H, V108, P408, DOI 10.1093/trstmh/tru078
- Vitoria M, 2020, J INT AIDS SOC, V23, DOI 10.1002/JIA2.25489
- Vizcarra P, 2020, LANCET HIV, V7, pE554, DOI 10.1016/S2352-3018(20)30164-8
- Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3